Abstract
Advanced support for quality of life in oncology: Brazilian private and public health insurance cancer patients' point of view
Journal of clinical oncology, Vol.35(15_suppl), pp.e18229-e18229
05/20/2017
DOI: 10.1200/JCO.2017.35.15_suppl.e18229
Abstract
Abstract only e18229 Background: Cancer patients suffer from burden symptoms and adverse events which compromise quality-of-life. Early palliative care involvement of metastatic non-small cell lung cancer patients has demonstrated increased overall survival. Advanced Support for Quality-of-Life in Oncology - ASQO - addresses cancer and its treatment complications aiming a safe cure or symptom control and dignified death. Measure cancer patients' background and interest about their disease is critical for planning care. To study the point of view of cancer patients about ASQO and compare private and public Brazilian health insurance cancer patients. Methods: An interview was performed and SPSS was used to find means and rates. The protocol was approved by Federal University of Pernambuco ethics committee and all patients signed informed consent Results: 48 patients were interviewed, 28 at Hospital das Clinicas Federal University of Pernambuco and 20 at ÓNKOS Oncology. Attached tables show demographic data and patients’ background, interest and opinion. The topics on which more and less patients’ background were “Chances of cure” (85%) and “Fertility” (25%); Fertility (59%) and participation in clinical research (40%) were the subjects for which more and less patients wanted additional information; Among those patients who wanted additional information about any topic, the theme on which more and less comments were made were “Pain” (100%) and individualization of treatment (10%); Goals of treatment (89%) and fertility (41%) were the subjects that more and less patients were satisfied with the information received Conclusions: In Brazil, the majority of cancer patients don’t have the opportunity to discuss treatment goals and fertility is not widely discussed with them. This translated into highest percentage of interest in the subject and a higher degree of dissatisfaction with the information received, despite median age of 58 years in the study population. The high prevalence of uncontrolled pain reflected in 100% of responders have made additional comments, indicating a need for health professionals education to adequately manage this symptom. Clinical trial information: CAAE 50921215.8.0000.5208.
Details
- Title: Subtitle
- Advanced support for quality of life in oncology: Brazilian private and public health insurance cancer patients' point of view
- Creators
- Gustavo Fernandes Godoy AlmeidaMauricio Assuero Lima de Freitas - FADE Federal University of Pernambuco, Recife, BrazilMarcela Silva Costa - Centro Universitário Maurício de NassauRafaela Batista da Silva Cordeiro - Centro Universitário Maurício de NassauEvandro Lopes de Barros Filho - Centro Universitário Maurício de NassauGabriela Pereira Barreto dos Reis - Centro Universitário Maurício de NassauJuliana Oliveira Santos - Centro Universitário Maurício de NassauLuisa Conceicao Violet Jatoba - Centro Universitário Maurício de NassauEstevao Michel Santana de Luna - Centro Universitário Maurício de NassauLauro Vinicius Machado da Silva - Centro Universitário Maurício de NassauAlexandro Machado - Federal University of Pernambuco, Recife, BrazilGabriel Brito Barbosa - Centro Universitário Maurício de NassauThais Milla Franco de Freitas - Centro Universitário Maurício de NassauLuiz Alberto Reis Mattos - Hospital das Clínicas da Universidade Federal de PernambucoAdvanced Support for Quality-of-life in Oncology (ASQO)
- Resource Type
- Abstract
- Publication Details
- Journal of clinical oncology, Vol.35(15_suppl), pp.e18229-e18229
- DOI
- 10.1200/JCO.2017.35.15_suppl.e18229
- ISSN
- 0732-183X
- eISSN
- 1527-7755
- Publisher
- AMER SOC CLINICAL ONCOLOGY
- Language
- English
- Date published
- 05/20/2017
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
- Record Identifier
- 9985150646702771
Metrics
1 Record Views